313 related articles for article (PubMed ID: 34967405)
21. Evaluation of pharmacogenomic evidence for drugs related to
Reeves AA; Hopefl R; Deb S
Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916
[TBL] [Abstract][Full Text] [Related]
22. Integrating pharmacogenomics into precision pain management.
Bates J; Fudin J; Patel JN
Support Care Cancer; 2022 Dec; 30(12):10453-10459. PubMed ID: 36271058
[TBL] [Abstract][Full Text] [Related]
23. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
24. An EMR-Based Approach to Determine Frequency, Prescribing Pattern, and Characteristics of Patients Receiving Drugs with Pharmacogenomic Guidelines.
MacKinnon GE; Mills M; Stoddard A; Urrutia RA; Broeckel U
Pharmacy (Basel); 2023 Nov; 11(6):. PubMed ID: 37987388
[TBL] [Abstract][Full Text] [Related]
25. Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug-Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients.
Westergaard N; Søgaard Nielsen R; Jørgensen S; Vermehren C
J Pers Med; 2020 Jan; 10(1):. PubMed ID: 31963319
[TBL] [Abstract][Full Text] [Related]
26. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
27. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
28. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics in practice: a review and implementation guide.
Kabbani D; Akika R; Wahid A; Daly AK; Cascorbi I; Zgheib NK
Front Pharmacol; 2023; 14():1189976. PubMed ID: 37274118
[TBL] [Abstract][Full Text] [Related]
30. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.
Shugg T; Ly RC; Rowe EJ; Philips S; Hyder MA; Radovich M; Rosenman MB; Pratt VM; Callaghan JT; Desta Z; Schneider BP; Skaar TC
JCO Precis Oncol; 2022 Feb; 6():e2100312. PubMed ID: 35201852
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics in chronic pain therapy: from disease to treatment and challenges for clinical practice.
Yamamoto PA; Conchon Costa AC; Lauretti GR; de Moraes NV
Pharmacogenomics; 2019 Aug; 20(13):971-982. PubMed ID: 31486733
[TBL] [Abstract][Full Text] [Related]
32. The Prevalence and Features of Medications With Actionable Pharmacogenomic Biomarkers Prescribed to Kidney Transplant Recipients.
Chang YL; Hsiao TH; Wu MF; Chen CH
Transplant Proc; 2023 May; 55(4):862-866. PubMed ID: 37127518
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels.
Yoon DY; Lee S; Ban MS; Jang IJ; Lee S
Transl Clin Pharmacol; 2020 Dec; 28(4):189-198. PubMed ID: 33425802
[TBL] [Abstract][Full Text] [Related]
34. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
Blazy C; Ellingrod V; Ward K
Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
[TBL] [Abstract][Full Text] [Related]
35. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
36. Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
Jameson A; Faisal M; Fylan B; Bristow GC; Sohal J; Dalton C; Sagoo GS; Cardno AG; McLean SL
J Psychopharmacol; 2024 Apr; 38(4):382-394. PubMed ID: 38494658
[TBL] [Abstract][Full Text] [Related]
37. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
[TBL] [Abstract][Full Text] [Related]
38. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice.
Shahabi P; Dubé MP
Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112
[TBL] [Abstract][Full Text] [Related]
40. Use of Pharmacogenetic Drugs by the Dutch Population.
Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
Front Genet; 2019; 10():567. PubMed ID: 31312209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
